Diabetes Self-Management Blog

Hot on the heels of similar news about sister drug rosiglitazone (brand name Avandia; reported here in the story ”Diabetes Drug Linked to Fracture Risk”), the Type 2 diabetes drug pioglitazone (Actos) has been linked to increased risk of certain kinds of bone fractures in women.

Pioglitazone and rosiglitazone are both members of the drug class known as thiazolidinediones. These drugs prompt the body’s tissues to use insulin more effectively and the liver to produce less glucose.

Last week, the U.S. Food and Drug Administration (FDA) and pioglitazone manufacturer Takeda Pharmaceuticals North America, Inc., released a letter alerting health-care professionals and consumers that increased reports of fractures had been found in women who take the drug. The warning was based on an analysis of data from multiple clinical trials in Takeda’s database. The trials, which included more than 15,000 participants, compared drug therapy with pioglitazone to therapy with either another diabetes drug or a placebo. While they were not designed to study pioglitazone’s effect on bone, the trials did record “adverse events,” such as fractures.

The analysis of data from these trials showed that women who took pioglitazone were more likely to experience fractures of the forearm, hand, wrist, foot, ankle, or leg—but not of the hip or spine, sites usually associated with postmenopausal osteoporosis (degenerative bone disease). Men who took pioglitazone did not experience any increased risk of fractures.

Until more research can be done on the effect of thiazolidinediones on fracture risk, the mechanism by which they are associated with increased fracture rates in women will remain unclear. In the meantime, the FDA and the drugs’ manufacturers encourage health-care providers to consider the risk of fracture when choosing to begin or continue drug therapy with pioglitazone or rosiglitazone in women.

Pioglitazone is currently sold as the stand-alone drug Actos, in combination with metformin as Actoplus met, and in combination with the sulfonylurea drug glimepiride as duetact.

POST A COMMENT       
  

Comments
  1. Makes me glad I started right away on insulin and never tried the oral meds.

    Posted by Ephrenia |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.


Type 2 Diabetes
Discovering I Had Type 2 Diabetes (10/17/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)
Metformin Study Currently Recruiting (08/19/14)

Oral Medicines
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
New SGLT Drugs Coming (07/23/14)

Diabetes News
FDA Approves Remote Glucose-Monitoring Technology (10/24/14)
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.